The University of Minnesota finalises second license with startup International Cardio for ultrasound technology to tackle artery disease.

The University of Minnesota has finalised a second license with International Cardio Corporation (ICC) for an ultrasound-based technology which could benefit millions with artery disease.

It follows a license in 2011 between the two for technologies which treat plaque build-up in the artery walls. The build-up leads to peripheral artery disease, a condition that affects over eight million in the US and is common with Americans suffering from diabetes.

Dennis Sellke, chief executive of ICC, said: “We were very excited…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?